Pharmacophore an International Research Journal
Submit Manuscript
Open Access | Published: 2023 - Issue 1

The Effectiveness of The Use of Macrolide Antibiotic in Infectious Diseases Download PDF

, , , , ,

Modern principles of treatment involve the frequent use of antibiotics in infectious diseases. One of the most considered antibiotics is the macrolide group. It is these drugs that have relatively few side effects, while at the same time preventing the development of a significant number of dangerous microorganisms and intracellular parasites. A significant disadvantage of macrolide antibiotics is the resistance to their action by many bacteria. This article investigates the preventive effectiveness of three types of macrolide antibiotics in infectious diseases and dysbiosis in the example of laboratory animals. Observations were carried out on four similar groups of laboratory animals, which received erythromycin, azithromycin, and midecamycin as prophylactic drugs. The fourth group was a control group that did not receive any treatment. According to the results of the study, a conclusion was made about the effectiveness of the drugs used. In infectious diseases, the final effectiveness of erythromycin was 60%, azithromycin - 80%, and midecamycin - 55%. In dysbiosis, the efficacy of erythromycin and azithromycin was 100%, and of midecamycin - 90%. The use of macrolide antibiotics for preventive purposes also significantly reduced mortality rates, which in the control were 35% for infectious diseases and 10% for dysbiosis.

Cite this article
Rasueva MK, Medalieva AZ, Shengelaya PD, Allahverdiyeva DCK, Pule AK, Gasanov ZA. The Effectiveness of The Use of Macrolide Antibiotic in Infectious Diseases. Pharmacophore. 2023;14(1):87-92.
Rasueva, M. K., Medalieva, A. Z., Shengelaya, P. D., Allahverdiyeva, D. C. K., Pule, A. K., & Gasanov, Z. A. (2023). The Effectiveness of The Use of Macrolide Antibiotic in Infectious Diseases. Pharmacophore, 14(1), 87-92.

QR code:

Short Link:
Views: 1074

Downloads: 151
Quick Access

ISSN: 2229-5402

Copyright © 2024 Pharmacophore
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.